Selective Antigen Specific T Cells and CAR T Cells in Subjects With Relapsed/Refractory Embryonal Tumors (SABRE)

NCT07172958 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Rhabdomyosarcoma
Ewing Sarcoma
Neuroblastoma
Wilms Tumor

Interventions

BIOLOGICAL: Selective Antigen Specific dTβRII-expressing T cells combined with B7-H3 CAR T cells

Sponsor

Children's National Research Institute

Collaborators

National Cancer Institute (NCI)
Cancer Research UK
The Mark Foundation for Cancer Research